Yi-Ping Yang

654 total citations
8 papers, 311 citations indexed

About

Yi-Ping Yang is a scholar working on Infectious Diseases, Neurology and Pharmacology. According to data from OpenAlex, Yi-Ping Yang has authored 8 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Neurology and 1 paper in Pharmacology. Recurrent topics in Yi-Ping Yang's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Long-Term Effects of COVID-19 (2 papers). Yi-Ping Yang is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Long-Term Effects of COVID-19 (2 papers). Yi-Ping Yang collaborates with scholars based in Taiwan and Hong Kong. Yi-Ping Yang's co-authors include Yi-Tsung Lin, Chian‐Shiu Chien, Yung‐Hung Luo, Wei-Yi Lai, Mong‐Lien Wang, Shih-Hwa Chiou, Aliaksandr A. Yarmishyn, Pei‐Ching Chang, Yanwen Liang and Yann-Jang Chen and has published in prestigious journals such as Frontiers in Immunology and Journal of the Chinese Medical Association.

In The Last Decade

Yi-Ping Yang

8 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Ping Yang Taiwan 5 190 72 37 30 28 8 311
Shannon Steele Canada 6 224 1.2× 86 1.2× 45 1.2× 19 0.6× 29 1.0× 10 379
Kamla Kant India 9 218 1.1× 96 1.3× 48 1.3× 28 0.9× 12 0.4× 27 338
Luis Unigarro Ecuador 3 176 0.9× 61 0.8× 28 0.8× 17 0.6× 29 1.0× 5 308
Maheswari Kulandhasamy India 8 218 1.1× 99 1.4× 49 1.3× 29 1.0× 12 0.4× 17 296
Yuchong Li China 7 187 1.0× 33 0.5× 42 1.1× 20 0.7× 22 0.8× 14 308
Hossein Chiti Iran 4 140 0.7× 43 0.6× 29 0.8× 15 0.5× 15 0.5× 5 251
Doménica Cevallos-Robalino Ecuador 4 178 0.9× 60 0.8× 27 0.7× 17 0.6× 29 1.0× 5 314
Dan Jiang China 9 195 1.0× 116 1.6× 37 1.0× 27 0.9× 17 0.6× 23 382
Zhiguo Zhou China 10 165 0.9× 87 1.2× 42 1.1× 24 0.8× 13 0.5× 16 289
Javid Azadbakht Iran 7 128 0.7× 58 0.8× 41 1.1× 15 0.5× 47 1.7× 28 292

Countries citing papers authored by Yi-Ping Yang

Since Specialization
Citations

This map shows the geographic impact of Yi-Ping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Ping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Ping Yang more than expected).

Fields of papers citing papers by Yi-Ping Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Ping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Ping Yang. The network helps show where Yi-Ping Yang may publish in the future.

Co-authorship network of co-authors of Yi-Ping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Ping Yang. A scholar is included among the top collaborators of Yi-Ping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Ping Yang. Yi-Ping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liang, Yanwen, Mong‐Lien Wang, Chian‐Shiu Chien, et al.. (2020). Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Frontiers in Immunology. 11. 1022–1022. 134 indexed citations
2.
Lin, Ting‐Yu, et al.. (2020). Cardiovascular manifestation and treatment in COVID-19. Journal of the Chinese Medical Association. 83(8). 704–709. 27 indexed citations
3.
Chen, Min‐Chi, Yung‐Tai Chen, Yi-Ping Yang, et al.. (2020). Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic. Journal of the Chinese Medical Association. 83(9). 809–811. 4 indexed citations
4.
Lai, Wei-Yi, Jun‐Ren Sun, Yueh Chien, et al.. (2020). Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic. Journal of the Chinese Medical Association. 84(1). 9–13. 2 indexed citations
5.
Wang, Sheng‐Fan, Kuan-Hsuan Chen, Aliaksandr A. Yarmishyn, et al.. (2020). The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2. Journal of the Chinese Medical Association. 83(8). 712–718. 1 indexed citations
6.
Huang, Hsin-Hui, Peng‐Hui Wang, Yi-Ping Yang, et al.. (2020). A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system. Journal of the Chinese Medical Association. 83(10). 895–897. 19 indexed citations
7.
Chen, Ju‐Yu, et al.. (2020). Use of radiographic features in COVID-19 diagnosis: Challenges and perspectives. Journal of the Chinese Medical Association. 83(7). 644–647. 19 indexed citations
8.
Tsai, Ping‐Hsing, Wei-Yi Lai, Yi-Ying Lin, et al.. (2020). Clinical manifestation and disease progression in COVID-19 infection. Journal of the Chinese Medical Association. 84(1). 3–8. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026